Evidence map›Paper›PMID 33112758›Full record

ArticleJournal of medical Internet research2020

Status of Institutional Review Board Meetings Conducted Through Web Conference Systems in Japanese National University Hospitals During the COVID-19 Pandemic: Questionnaire Study.

Kenta Yagi, Kazuki Maeda, Satoshi Sakaguchi, Masayuki Chuma, Yasutaka Sato, Chikako Kane, Akiyo Akaishi, Keisuke Ishizawa, Hiroaki Yanagawa

Abstract read
In one paragraph

Article in Journal of medical Internet research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kenta YagiClinical Research Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan.ORCID 0000-0003-0869-5786
Kazuki MaedaClinical Research Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan.ORCID 0000-0002-3930-2052
Satoshi SakaguchiClinical Research Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan.ORCID 0000-0002-8916-636X
Masayuki ChumaClinical Research Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan.ORCID 0000-0002-5755-283X
Yasutaka SatoClinical Research Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan.ORCID 0000-0001-8179-2211
Chikako KaneClinical Research Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan.ORCID 0000-0001-9455-1505
Akiyo AkaishiClinical Research Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan.ORCID 0000-0002-3621-5156
Keisuke IshizawaDepartment of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Kuramoto-cho, Tokushima, Japan.ORCID 0000-0003-1971-7696
Hiroaki YanagawaClinical Research Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan.ORCID 0000-0002-6734-2262

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWith the global proliferation of the novel COVID-19 disease, conventionally conducting institutional review board (IRB) meetings has become a difficult task. Amid concerns about the suspension of drug development due to delays within IRBs, it has been suggested that IRB meetings should be temporarily conducted via the internet.

objectiveThis study aimed to elucidate the current status of IRB meetings conducted through web conference systems.

methodsA survey on conducting IRB meetings through web conference systems was administered to Japanese national university hospitals. Respondents were in charge of operating IRB offices at different universities. This study was not a randomized controlled trial.

resultsThe survey was performed at 42 facilities between the end of May and early June, 2020, immediately after the state of emergency was lifted in Japan. The survey yielded a response rate of 74% (31/42). Additionally, while 68% (21/31) of facilities introduced web conference systems for IRB meetings, 13% (4/31) of the surveyed facilities postponed IRB meetings. Therefore, we conducted a further survey of 21 facilities that implemented web conference systems for IRB meetings. According to 71% (15/21) of the respondents, there was no financial burden for implementing these systems, as they were free of charge. In 90% (19/21) of the facilities, IRB meetings through web conference systems were already being conducted with personal electronic devices. Furthermore, in 48% (10/21) of facilities, a web conference system was used in conjunction with face-to-face meetings.

conclusionsDue to the COVID-19 pandemic, the number of reviews in clinical trial core hospitals has decreased. This suggests that the development of pharmaceuticals has stagnated because of COVID-19. According to 71% (15/21) of the respondents who conducted IRB meetings through web conference systems, the cost of introducing such meetings was US $0, showing a negligible financial burden. Moreover, it was shown that online deliberations could be carried out in the same manner as face-to-face meetings, as 86% (18/21) of facilities stated that the number of comments made by board members did not change. To improve the quality of IRB meetings conducted through web conference systems, it is necessary to further examine camera use and the content displayed on members' screens during meetings. Further examination of all members who use web conference systems is required. Our measures for addressing the requests and problems identified in our study could potentially be considered protocols for future IRB meetings, when the COVID-19 pandemic has passed and face-to-face meetings are possible again. This study also highlights the importance of developing web conference systems for IRB meetings to respond to future unforeseen pandemics.

Indexed as

Coronavirus InfectionsHospitals, UniversityInternetPandemicsPneumonia, ViralSurveys and QuestionnairesCOVID-19Ethics Committees, ResearchHumansJapanVideoconferencingclinical trialCOVID-19drug developmenthospitalInstitutional Review BoardIRBJapanREBResearch Ethics Boardsurveyteleconferenceweb conference

Identifiers

PMID33112758
PMCPMC7683025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.